Terms ending in 2035
Every in-force patent on AstraZeneca AB's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,183,020 | Pharmaceutical Compositions Comprising AZD9291 In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 9,815,805 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 10,287,258 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 10,669,245 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 11,117,874 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 11,655,221 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 11,655,222 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 11,655,223 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 11,655,224 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| US 11,667,615 | Certain (2S)-N-[(1S)-1-Cyano-2-Phenylethyl]-1,4-Oxazepane-2-Carboxamides as Dipeptidyl Peptidase 1 Inhibitors In force · Low confidence | AstraZeneca AB | In force | Low confidence | |
| 32 more term ends in 2035 · Pro | |||||
10 of 42 patents shown. Soonest term end first, then patent number.
Pro members see all 42.
35 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.